Global Automation in Biopharmaceutical Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201080153 | Category: Service & Software | Pages: 101 | Format: PDF | Published Date: October 11,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Automation in Biopharmaceutical market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Automation in Biopharmaceutical market size is estimated to be worth US$ 1037.9 million in 2021 and is forecast to a readjusted size of USD 1553.8 million by 2028 with a CAGR of 5.9% during review period. Research and Development accounting for  % of the Automation in Biopharmaceutical global market in 2021, is projected to value USD   million by 2028, growing at a  % CAGR in next six years. While Clinical Stage Automation segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Automation in Biopharmaceutical include Danaher, GE, PerkinElmer, Tecan Trading, and Thermo Fisher Scientific, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Automation in Biopharmaceutical market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Clinical Stage Automation
    Drug Discovery Stage Automation
Market segment by Application, can be divided into
    Research and Development
    Clinical
Market segment by players, this report covers
    Danaher
    GE
    PerkinElmer
    Tecan Trading
    Thermo Fisher Scientific
    Bruker
    Peak Analysis and Automation
    Waters
    Capsugel
    RheoSense
    Eirechrom
    BioProcess International
    Novasep
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Automation in Biopharmaceutical product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Automation in Biopharmaceutical, with revenue, gross margin and global market share of Automation in Biopharmaceutical from 2019 to 2022.
Chapter 3, the Automation in Biopharmaceutical competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Automation in Biopharmaceutical market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Automation in Biopharmaceutical research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Automation in Biopharmaceutical
    1.2 Classification of Automation in Biopharmaceutical by Type
        1.2.1 Overview: Global Automation in Biopharmaceutical Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Automation in Biopharmaceutical Revenue Market Share by Type in 2021
        1.2.3 Clinical Stage Automation
        1.2.4 Drug Discovery Stage Automation
    1.3 Global Automation in Biopharmaceutical Market by Application
        1.3.1 Overview: Global Automation in Biopharmaceutical Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Research and Development
        1.3.3 Clinical
    1.4 Global Automation in Biopharmaceutical Market Size & Forecast
    1.5 Global Automation in Biopharmaceutical Market Size and Forecast by Region
        1.5.1 Global Automation in Biopharmaceutical Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Automation in Biopharmaceutical Market Size by Region, (2017-2022)
        1.5.3 North America Automation in Biopharmaceutical Market Size and Prospect (2017-2028)
        1.5.4 Europe Automation in Biopharmaceutical Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Automation in Biopharmaceutical Market Size and Prospect (2017-2028)
        1.5.6 South America Automation in Biopharmaceutical Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Automation in Biopharmaceutical Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Automation in Biopharmaceutical Market Drivers
        1.6.2 Automation in Biopharmaceutical Market Restraints
        1.6.3 Automation in Biopharmaceutical Trends Analysis
2 Company Profiles
    2.1 Danaher
        2.1.1 Danaher Details
        2.1.2 Danaher Major Business
        2.1.3 Danaher Automation in Biopharmaceutical Product and Solutions
        2.1.4 Danaher Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Danaher Recent Developments and Future Plans
    2.2 GE
        2.2.1 GE Details
        2.2.2 GE Major Business
        2.2.3 GE Automation in Biopharmaceutical Product and Solutions
        2.2.4 GE Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 GE Recent Developments and Future Plans
    2.3 PerkinElmer
        2.3.1 PerkinElmer Details
        2.3.2 PerkinElmer Major Business
        2.3.3 PerkinElmer Automation in Biopharmaceutical Product and Solutions
        2.3.4 PerkinElmer Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 PerkinElmer Recent Developments and Future Plans
    2.4 Tecan Trading
        2.4.1 Tecan Trading Details
        2.4.2 Tecan Trading Major Business
        2.4.3 Tecan Trading Automation in Biopharmaceutical Product and Solutions
        2.4.4 Tecan Trading Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Tecan Trading Recent Developments and Future Plans
    2.5 Thermo Fisher Scientific
        2.5.1 Thermo Fisher Scientific Details
        2.5.2 Thermo Fisher Scientific Major Business
        2.5.3 Thermo Fisher Scientific Automation in Biopharmaceutical Product and Solutions
        2.5.4 Thermo Fisher Scientific Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
    2.6 Bruker
        2.6.1 Bruker Details
        2.6.2 Bruker Major Business
        2.6.3 Bruker Automation in Biopharmaceutical Product and Solutions
        2.6.4 Bruker Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Bruker Recent Developments and Future Plans
    2.7 Peak Analysis and Automation
        2.7.1 Peak Analysis and Automation Details
        2.7.2 Peak Analysis and Automation Major Business
        2.7.3 Peak Analysis and Automation Automation in Biopharmaceutical Product and Solutions
        2.7.4 Peak Analysis and Automation Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Peak Analysis and Automation Recent Developments and Future Plans
    2.8 Waters
        2.8.1 Waters Details
        2.8.2 Waters Major Business
        2.8.3 Waters Automation in Biopharmaceutical Product and Solutions
        2.8.4 Waters Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Waters Recent Developments and Future Plans
    2.9 Capsugel
        2.9.1 Capsugel Details
        2.9.2 Capsugel Major Business
        2.9.3 Capsugel Automation in Biopharmaceutical Product and Solutions
        2.9.4 Capsugel Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Capsugel Recent Developments and Future Plans
    2.10 RheoSense 
        2.10.1 RheoSense Details
        2.10.2 RheoSense Major Business
        2.10.3 RheoSense Automation in Biopharmaceutical Product and Solutions
        2.10.4 RheoSense Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 RheoSense Recent Developments and Future Plans
    2.11 Eirechrom
        2.11.1 Eirechrom Details
        2.11.2 Eirechrom Major Business
        2.11.3 Eirechrom Automation in Biopharmaceutical Product and Solutions
        2.11.4 Eirechrom Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Eirechrom Recent Developments and Future Plans
    2.12 BioProcess International
        2.12.1 BioProcess International Details
        2.12.2 BioProcess International Major Business
        2.12.3 BioProcess International Automation in Biopharmaceutical Product and Solutions
        2.12.4 BioProcess International Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 BioProcess International Recent Developments and Future Plans
    2.13 Novasep
        2.13.1 Novasep Details
        2.13.2 Novasep Major Business
        2.13.3 Novasep Automation in Biopharmaceutical Product and Solutions
        2.13.4 Novasep Automation in Biopharmaceutical Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Novasep Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Automation in Biopharmaceutical Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Automation in Biopharmaceutical Players Market Share in 2021
        3.2.2 Top 10 Automation in Biopharmaceutical Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Automation in Biopharmaceutical Players Head Office, Products and Services Provided
    3.4 Automation in Biopharmaceutical Mergers & Acquisitions
    3.5 Automation in Biopharmaceutical New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Automation in Biopharmaceutical Revenue and Market Share by Type (2017-2022)
    4.2 Global Automation in Biopharmaceutical Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Automation in Biopharmaceutical Revenue Market Share by Application (2017-2022)
    5.2 Global Automation in Biopharmaceutical Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Automation in Biopharmaceutical Revenue by Type (2017-2028)
    6.2 North America Automation in Biopharmaceutical Revenue by Application (2017-2028)
    6.3 North America Automation in Biopharmaceutical Market Size by Country
        6.3.1 North America Automation in Biopharmaceutical Revenue by Country (2017-2028)
        6.3.2 United States Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
        6.3.3 Canada Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
        6.3.4 Mexico Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Automation in Biopharmaceutical Revenue by Type (2017-2028)
    7.2 Europe Automation in Biopharmaceutical Revenue by Application (2017-2028)
    7.3 Europe Automation in Biopharmaceutical Market Size by Country
        7.3.1 Europe Automation in Biopharmaceutical Revenue by Country (2017-2028)
        7.3.2 Germany Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
        7.3.3 France Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
        7.3.5 Russia Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
        7.3.6 Italy Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Automation in Biopharmaceutical Revenue by Type (2017-2028)
    8.2 Asia-Pacific Automation in Biopharmaceutical Revenue by Application (2017-2028)
    8.3 Asia-Pacific Automation in Biopharmaceutical Market Size by Region
        8.3.1 Asia-Pacific Automation in Biopharmaceutical Revenue by Region (2017-2028)
        8.3.2 China Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
        8.3.3 Japan Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
        8.3.4 South Korea Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
        8.3.5 India Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
        8.3.7 Australia Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Automation in Biopharmaceutical Revenue by Type (2017-2028)
    9.2 South America Automation in Biopharmaceutical Revenue by Application (2017-2028)
    9.3 South America Automation in Biopharmaceutical Market Size by Country
        9.3.1 South America Automation in Biopharmaceutical Revenue by Country (2017-2028)
        9.3.2 Brazil Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
        9.3.3 Argentina Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Automation in Biopharmaceutical Revenue by Type (2017-2028)
    10.2 Middle East & Africa Automation in Biopharmaceutical Revenue by Application (2017-2028)
    10.3 Middle East & Africa Automation in Biopharmaceutical Market Size by Country
        10.3.1 Middle East & Africa Automation in Biopharmaceutical Revenue by Country (2017-2028)
        10.3.2 Turkey Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
        10.3.4 UAE Automation in Biopharmaceutical Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Automation in Biopharmaceutical Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?